Innate Pharma (IPHA) — Financial Flexibility Index
Innate Pharma (IPHA) has a Financial Flexibility Index of -0.28x as of March 2026. Free cash flow of $-23.31 Million (operating CF $-23.40 Million minus capex $85.05K) represents 0% of total liabilities ($84.39 Million). Check Innate Pharma investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Innate Pharma Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Innate Pharma across 21 annual periods. For the full cash flow conversion analysis, see IPHA cash flow conversion.
Annual Financial Flexibility Index for Innate Pharma (2005–2025)
Year-by-year free cash flow to debt coverage for Innate Pharma. Explore cash flow to debt ratio of Innate Pharma to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.60x | $-50.54 Million | $-50.67 Million | $84.39 Million | ▼ -841.1% |
| 2024 | -0.06x | $-6.50 Million | $-6.90 Million | $102.22 Million | ▲ +72.1% |
| 2023 | -0.23x | $-30.21 Million | $-32.56 Million | $132.29 Million | ▼ -94.6% |
| 2022 | -0.12x | $-18.03 Million | $-19.15 Million | $153.71 Million | ▲ +67.1% |
| 2021 | -0.36x | $-57.13 Million | $-58.46 Million | $160.06 Million | ▼ -33.4% |
| 2020 | -0.27x | $-40.52 Million | $-51.81 Million | $151.45 Million | ▼ -149.1% |
| 2019 | 0.55x | $100.33 Million | $34.92 Million | $183.94 Million | ▲ +598.0% |
| 2018 | -0.11x | $-31.10 Million | $-32.53 Million | $283.98 Million | ▲ +55.9% |
| 2017 | -0.25x | $-42.03 Million | $-48.06 Million | $169.07 Million | ▼ -76.9% |
| 2016 | -0.14x | $-27.46 Million | $-36.85 Million | $195.41 Million | ▼ -115.3% |
| 2015 | 0.92x | $215.31 Million | $207.91 Million | $233.89 Million | ▲ +193.6% |
| 2014 | -0.98x | $-15.79 Million | $-18.13 Million | $16.06 Million | ▼ -45.5% |
| 2013 | -0.68x | $-10.53 Million | $-10.97 Million | $15.60 Million | ▼ -82.0% |
| 2012 | -0.37x | $-9.25 Million | $-10.47 Million | $24.93 Million | ▼ -193.4% |
| 2011 | 0.40x | $13.31 Million | $12.99 Million | $33.48 Million | ▲ +144.2% |
| 2010 | -0.90x | $-13.04 Million | $-13.45 Million | $14.49 Million | ▼ -183.6% |
| 2009 | -0.32x | $-5.42 Million | $-5.94 Million | $17.10 Million | ▲ +51.8% |
| 2008 | -0.66x | $-12.84 Million | $-14.74 Million | $19.52 Million | ▼ -11.6% |
| 2007 | -0.59x | $-7.99 Million | $-9.28 Million | $13.55 Million | ▼ -783.1% |
| 2006 | 0.09x | $1.11 Million | $360.00K | $12.89 Million | ▲ +105.7% |
| 2005 | -1.52x | $-7.14 Million | $-7.25 Million | $4.70 Million | — |